awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q58731660-5B1F25EA-BFC4-4A0F-8C98-C24B779A8237
Q58731660-5B1F25EA-BFC4-4A0F-8C98-C24B779A8237
BestRank
Statement
http://www.wikidata.org/entity/statement/Q58731660-5B1F25EA-BFC4-4A0F-8C98-C24B779A8237
Akt and mTORC1 signaling as predictive biomarkers for the EGFR antibody nimotuzumab in glioblastoma
P2860
Q58731660-5B1F25EA-BFC4-4A0F-8C98-C24B779A8237
BestRank
Statement
http://www.wikidata.org/entity/statement/Q58731660-5B1F25EA-BFC4-4A0F-8C98-C24B779A8237
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
b8529caff47399c9e5bc3e1a83d9bfd5f2a6ad49
P2860
Combined treatment of Nimotuzumab and rapamycin is effective against temozolomide-resistant human gliomas regardless of the EGFR mutation status.